Case Report of Human Patient with Opioid Toxicity and Tirzepatide

A case was reported where a 53-year-old man with primary progressive multiple sclerosis and quadriplegia experienced opioid toxicity after starting tirzepatide, requiring naloxone for respiratory failure. Symptoms included acute kidney injury and dehydration-related issues.

Tags: #MSResearch
Most relevant to: —
Source: Read original source (PMID 42807130)

This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

This case highlights a potentially significant drug interaction between tirzepatide and chronic opioid therapy, stressing the need for increased awareness among clinicians as such therapies are commonly co-prescribed.

What this does not prove

Being a single case report limits generalizability and lacks formal pharmacokinetic data that would provide insights into this interaction.

Next milestone

No next milestone was established from the available source.

Study facts

Study design: Not reported
Participants / samples: 1 · basis not reported
Randomised: Not reported
Controlled: Not reported
Primary endpoint met: Not reported
Relevant MS type: Not reported
Publication date: 2026-08-28
Evidence reviewed: Abstract only
Regulatory approval: Not reported
Research areas: Not classified

Original sources

Primary evidenceOpioid Toxicity Associated With Tirzepatide in a Patient on Chronic Oral Morphine. ↗DOI: 10.7759/cureus.115380

Supporting passages (5)

subjectsWe report the first case of life-threatening opioid toxicity precipitated by tirzepatide initiation in a patient on chronic oral sustained-action opioid therapy.

sample sizeThis case highlights a previously unrecognized, clinically significant drug interaction with urgent implications as GLP-1-based therapies are increasingly co-prescribed with chronic opioid therapy, underscoring the need for clinician vigilance and formal pharmacokinetic study.

publication datePublication date: 2026-08-28

findingsWe report the first case of life-threatening opioid toxicity precipitated by tirzepatide initiation in a patient on chronic oral sustained-action opioid therapy.

limitationsTitle: Opioid Toxicity Associated With Tirzepatide in a Patient on Chronic Oral Morphine.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.